Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant

NCT04494061 is registered in ClinicalTrials.gov with Swedish Orphan Biovitrum as lead sponsor.

NCT NCT04494061
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04494061 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Investigate Interferon Gamma (IFNɣ) Signature in Patients Post HSCT and in Patients With Impaired HSC Proliferation Pre-transplant
Lead sponsor
Swedish Orphan Biovitrum
Phase
Observational
Overall status
Terminated
Start date
November 16, 2020
Completion date
August 31, 2022
Enrollment
101 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

graft failure